CINECA IRIS Institutional Research Information System

Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies.

GUALANO, MARIA ROSARIA;
2010-01-01
2010
TUMORI
96
385
391
Antibodies; Monoclonal; Humanized, Antibodies; therapeutic use, Antineoplastic Agents; therapeutic use, Antineoplastic Combined Chemotherapy Protocols; therapeutic use, Breast Neoplasms; chemistry/drug therapy/pathology, Deoxycytidine; administration /&/ dosage/analogs /&/ derivatives, Disease Progression, Female, Fluorouracil; administration /&/ dosage/analogs /&/ derivatives, Humans, Linear Models, Multivariate Analysis, Receptor; erbB-2; analysis, Vinblastine; administration /&/ dosage/analogs /&/ derivatives
A. Mannocci;E. De Feo;C. de Waure;M. L. Specchia;M. R. Gualano;C. Barone;W. Ricciardi;G. L. Torre
03A-Articolo su Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/96677
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 27
social impact